Company Filing History:
Years Active: 2021-2025
Title: Innovations by Basak Ozaslan in Diabetes Management
Introduction
Basak Ozaslan is an accomplished inventor based in Charlottesville, VA, who has made significant contributions to the field of diabetes management. With a focus on integrating psychological factors into medical devices, Ozaslan has developed innovative solutions aimed at improving patient outcomes.
Latest Patents
Ozaslan holds two notable patents that address the relationship between body mass index (BMI), psychological stress, and blood glucose dynamics in patients with insulin-dependent diabetes. The first patent describes a system and method for controlling insulin dispensing based on insulin sensitivity. This insulin device is equipped with a processor that receives insulin dosing schedule information, psychological stress level data, and BMI data. It also includes a sensor that generates blood glucose level measurements. The sensor is calibrated according to the psychological stress level and BMI data, allowing the processor to monitor changes in blood glucose levels and adjust insulin dispensing accordingly. This innovative approach aims to enhance the management of diabetes by considering the psychological aspects that affect blood glucose levels.
Career Highlights
Ozaslan is affiliated with the University of Virginia, where he continues to advance research in diabetes management technologies. His work emphasizes the importance of understanding the interplay between psychological stress and physiological responses in patients with diabetes.
Collaborations
Ozaslan collaborates with esteemed colleagues such as Stephen D. Patek and Linda Gonder-Frederick, who contribute to the interdisciplinary approach of his research.
Conclusion
Basak Ozaslan's innovative patents and research at the University of Virginia highlight the critical intersection of technology, psychology, and healthcare in managing diabetes. His work represents a significant advancement in the field, aiming to improve the quality of life for patients living with insulin-dependent diabetes.